Zürich (ots) - Der Verein Campaigning Summit Switzerland erhält den eidgenössischen Ritterschlag ...
/K I L L K I L L K I L L -- Bristol-Myers Squibb Medical Imaging/
Journalists and other readers should disregard the news release
"Bristol-Myers Squibb Medical Imaging Receives European Commission
Marketing Authorisation for Its Ultrasound Contrast Agent
LUMINITY(TM) (perflutren lipid microsphere)" NYSE:BMY, issued
earlier today. The release was issued prematurely by PR Newswire.
ots Originaltext: Bristol-Myers Squibb Medical Imaging
Im Internet recherchierbar: http://www.presseportal.ch